129
Participants
Start Date
May 13, 2020
Primary Completion Date
June 30, 2021
Study Completion Date
October 31, 2021
Hydroxychloroquine
Participants will receive a bottle containing 19 tablets of study medication. They will be instructed to take two tablets for the first three days and one tablet for the following 11 days. (400 mg/day for three days, followed by 200 mg/day for 11 days).
Placebo
Participants will receive a bottle containing 19 tablets of placebo. They will be instructed to take two tablets for the first three days and one tablet for the following 11 days.
Hospital Universitario Infanta Leonor, Madrid
Hospital Universitario de Torrejón, Torrejón de Ardoz
Hospital Universitario Fundación Alcorcón, Alcorcón
HM Puerta del Sur, Móstoles
Hospital General de Segovia, Segovia
Hospital del Mar, Barcelona
Hospital Clínic de Barcelona, Barcelona
Hospital de la Sant Creu i Sant Pau, Barcelona
Hospital Sant Joan de Déu, Esplugues de Llobregat
Hospital Clinic of Barcelona
OTHER
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
OTHER
University Hospital of Torrejon
OTHER
Fundación de investigación HM
OTHER
Hospital Sant Joan de Deu
OTHER
Hospital del Mar
OTHER
Hospital Universitario Infanta Leonor
OTHER
Hospital Universitario Fundación Alcorcón
OTHER
Hospital General de Segovia
OTHER
Institut Català de la Salut
OTHER
Barcelona Institute for Global Health
OTHER